ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in London, England

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Ovarian Cancer
Breast Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Lung Cancer

Endometrial Cancer trials near London, England, GBR:

Atezolizumab Trial in Endometrial Cancer - AtTEnd

Phase Ia study of Atezolizumab (NCT01375842) monotherapy in relapsed endometrial cancer were reported as abstract at ASCO 2017. Fif...

Active, not recruiting
Endometrial Cancer
Drug: Placebos
Drug: Atezolizumab

Phase 3

Mario Negri Institute for Pharmacological Research

London, United Kingdom and 92 other locations

The RAINBO umbrella program consists of four clinical trials investigating new adjuvant therapies in endometrial cancer patients. E ...

Enrolling
Endometrial Cancer
Radiation: Vaginal brachytherapy
Drug: Megestrol Acetate

Phase 2, Phase 3

Leiden University Medical Center (LUMC)

London, United Kingdom and 13 other locations

Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Doxorubicin

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

London, London, City Of, United Kingdom and 200 other locations

participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....

Active, not recruiting
Neoplasms
Drug: Paclitaxel
Drug: Carboplatin

Phase 3

Tesaro
Tesaro

London, United Kingdom and 162 other locations

choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...

Active, not recruiting
Endometrial Neoplasms
Drug: Doxorubicin
Drug: Paclitaxel

Phase 3

Eisai
Eisai

London, United Kingdom and 168 other locations

durvalumab (MEDI4736) in patients with relapsed gynaecological cancers to assess the response in groups of patients selected based on their ...

Enrolling
Gynaecological Cancers
Drug: Durvalumab
Drug: Ceralasertib

Phase 2

Institute of Cancer Research, United Kingdom

London, United Kingdom and 8 other locations

This clinical trial is studying advanced or metastatic solid tumors. Once a solid tumor has grown very large in one spot or has spr ...

Enrolling
Ovarian Neoplasms
Endometrial Neoplasms
Drug: disitamab vedotin

Phase 2

Seagen
Seagen

London, Other, United Kingdom and 41 other locations

) antibody (balstilimab), and to assess the maximum tolerated dose (MTD) in participants with advanced solid tumors. This study will also de...

Enrolling
Endometrial Cancer
Advanced Cancer
Drug: Balstilimab
Drug: Botensilimab

Phase 1

Agenus
Agenus

London, United Kingdom and 18 other locations

The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, wit...

Active, not recruiting
Endometrial Neoplasms
Drug: Placebo for pembrolizumab
Drug: Cisplatin

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

London, London, City Of, United Kingdom and 230 other locations

The purpose of this trial is to measure the following in participants with solid tumors who receive GEN1047:* The side effects seen with GEN...

Enrolling
Endometrial Cancer, Endometrial Neoplasm
Squamous Non Small Cell Lung Cancer (NSCLC-SCC)
Biological: GEN1047 is a bispecific antibody that induces T-cell mediated cytotoxicity of B7H4-positive tumor cells.

Phase 1, Phase 2

Genmab
Genmab

London, United Kingdom and 35 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems